M. Klüglich

Circadian blood pressure rhythm in primary and secondary hypertension.

M. Middeke, M. Klüglich, H. Holzgreve, 1991, Chronobiology international.

Efficacy of a tyrosine kinase inhibitor in idiopathic pulmonary fibrosis.

Luca Richeldi, G. Raghu, A. Nicholson, 2011, The New England journal of medicine.

Safety and pharmacokinetics of nintedanib and pirfenidone in idiopathic pulmonary fibrosis

M. Bando, Y. Sugiyama, Y. Kondoh, 2014, European Respiratory Journal.

Predictors and associations of the persistent airflow limitation phenotype in asthma: a post-hoc analysis of the ATLANTIS study.

J. Wedzicha, J. Vonk, K. Bønnelykke, 2022, The Lancet. Respiratory medicine.

Joint Population Pharmacokinetic/Pharmacodynamic Model for the Heart Rate Effects at Rest and at the End of Exercise for Cilobradine

N. Vélez de Mendizábal, I. Trocóniz, D. Trommeshauser, 2013, Pharmaceutical Research.

Chronopharmacology of captopril plus hydrochlorothiazide in hypertension: morning versus evening dosing.

M. Middeke, M. Klüglich, H. Holzgreve, 1991, Chronobiology international.